Cephaloglycin anhydrous

Cephaloglycin anhydrous - General Information

A cephalorsporin antibiotic.

Pharmacology of Cephaloglycin anhydrous

Cephaloglycin anhydrous is an antibiotic related to cephalosporin but no longer in common use. It is an orally absorbed derivative of cephalosporin C.

Additional information about Cephaloglycin anhydrous

Cephaloglycin anhydrous Indication: For treatment of severe infections caused by susceptible bacteria.
Mechanism Of Action: The bactericidal activity of cephaloglycin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Cephaloglycin
Synonyms: Not Available
Drug Category: Anti-Bacterial Agents
Drug Type: Small Molecule; Approved

Other Brand Names containing Cephaloglycin: CEG; Cefaloglicina [INN-Spanish]; Cefaloglycin; Cefaloglycine [INN-French]; Cefaloglycinum [INN-Latin]; Cephaloglycin anhydrous; Cephaloglycine; Cephaoglycin acid; D-Cephaloglycine; Kafocin; Kefglycin;
Absorption: Well absorbed following oral administration.
Toxicity (Overdose): Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions.
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Cephaloglycin anhydrous: Not Available
Chemical IUPAC Name: (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Chemical Formula: C18H19N3O6S
Cephaloglycin on Wikipedia: https://en.wikipedia.org/wiki/Cephaloglycin
Organisms Affected: Enteric bacteria and other eubacteria